Challenges and Solutions for the Benefit Assessment of Tumor-Agnostic Therapies in Germany

MLA

Juliane Schiller, et al. “Challenges and Solutions for the Benefit Assessment of Tumor-Agnostic Therapies in Germany.” Value in Health, vol. 26, June 2023, pp. 854–64. EBSCOhost, https://doi.org/10.1016/j.jval.2023.01.011.

APA

Juliane Schiller, Helene Eckhardt, Sarah Schmitter, Valerie A. Alber, & Tanja Rombey. (2023). Challenges and Solutions for the Benefit Assessment of Tumor-Agnostic Therapies in Germany. Value in Health, 26, 854–864. https://doi.org/10.1016/j.jval.2023.01.011

Chicago

Juliane Schiller, Helene Eckhardt, Sarah Schmitter, Valerie A. Alber, and Tanja Rombey. 2023. “Challenges and Solutions for the Benefit Assessment of Tumor-Agnostic Therapies in Germany.” Value in Health 26 (June): 854–64. doi:10.1016/j.jval.2023.01.011.